Matthew Ros

Director/Board Member at COGENT BIOSCIENCES, INC.

Net worth: 191 000 $ as of 30/06/2026

59 year

96 connections

Health Technology

Health Services

Consumer Services

Profile

Matthew E.
Ros is currently an Independent Director at Cogent Biosciences, Inc. since 2019.
Formerly, served as Chief Executive Officer & Director at Fore Biotherapeutics, Inc. from 2022 to 2023.
Worked at Bristol Myers Squibb Co. as Senior Director from 1990 to 2007.
Held the position of Senior Vice President-Commercial Operations at ARIAD Pharmaceuticals, Inc. from 2009 to 2010.
Was Vice President & Head-Franchise at Genzyme Corp.
from 2012 to 2014.
Served as Associate Vice President at Sanofi from 2010 to 2012 and later as COO, VP & Global Head-Oncology Business Unit at Sanofi from 2014 to 2016.
Held the role of Chief Financial Officer at Epizyme, Inc. in 2021.
Held a trustee position at Cancer Care, Inc. Served as Chief Operating Officer at Verastem, Inc. in 2025.
Education includes an undergraduate degree from The State University of New York, conferred in 1988.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VERASTEM, INC. 0.08%	01/04/2025	50,000 ( 0.08% )	191 000 $	30/06/2026
COGENT BIOSCIENCES, INC. -.--%	09/06/2026	0 ( -.--% )	- $	30/06/2026

Matthew Ros active positions

Companies	Position	Start
COGENT BIOSCIENCES, INC.	Director/Board Member	26/07/2019

All active positions of Matthew Ros

Former positions of Matthew Ros

Companies	Position	End
VERASTEM, INC.	Chief Operating Officer	15/12/2025
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Chief Executive Officer	01/08/2023
EPIZYME, INC.	Director of Finance/CFO	01/10/2021
SANOFI	Chief Operating Officer	01/05/2016
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	01/12/2014

See the detail of Matthew Ros's experience

Training of Matthew Ros

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Ros's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Cogent Biosciences, Inc. Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer	Health Technology
Cancer Care, Inc. Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Health Services
The State University of New York The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers	Health Technology
Verastem, Inc. Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs	Health Technology
Fore Biotherapeutics, Inc. Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies	Health Technology